Cellular ATP release by the cystic fibrosis transmembrane conductance regulator

被引:73
|
作者
Prat, AG [1 ]
Reisin, IL [1 ]
Ausiello, DA [1 ]
Cantiello, HF [1 ]
机构
[1] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
来源
关键词
ATP channels; ATP depletion; luminometry; C127I cells;
D O I
10.1152/ajpcell.1996.270.2.C538
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recent studies from our laboratory indicate that members of the ATP-binding cassette (ABC) family of transporters, including P-glycoprotein and cystic fibrosis transmembrane conductance regulator (CFTR), are ATP-permeable channels. The physiological relevance of this novel transport mechanism is largely unknown. In the present study, intra- and extracellular ATP content, cellular ATP release, and Oz consumption before and after adenosine 3',5'-cyclic monophosphate (cAMP) stimulation were determined to assess the role of CFTR in the transport of ATP under physiological conditions. The functional expression of CFTR by the stable transfection of mouse mammary carcinoma cells, C1271, with human epithelial CFTR cDNA resulted in a stimulated metabolism, since both basal and cAMP-inducible O-2 consumption were increased compared with mock-transfected cells. The stimulated (but not basal) O2 consumption was inhibited by diphenyl-2-carboxylic acid (DPC), a known inhibitor of CFTR. CFTR expression was also associated with the cAMP-activated and DPC-inhibitable release of intracellular ATP. The recovery of intracellular ATP from complete depletion after metabolic poisoning was also assessed under basal and cAMP-stimulated conditions. The various maneuvers indicate that CFTR may be an important contributor to the release of cellular ATP, which may help modify signal transduction pathways associated with secretory Cl- movement or other related processes. Changes in the CFTR-mediated delivery of nucleotides to the extracellular compartment may play an important role in the onset and reversal of the cystic fibrosis phenotype.
引用
收藏
页码:C538 / C545
页数:8
相关论文
共 50 条
  • [21] Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer
    Jieting Zhang
    Yan Wang
    Xiaohua Jiang
    Hsiao Chang Chan
    Cellular and Molecular Life Sciences, 2018, 75 : 1737 - 1756
  • [22] Purified cystic fibrosis transmembrane conductance regulator (CFTR) does not function as an ATP channel
    Li, CH
    Ramjeesingh, M
    Bear, CE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (20) : 11623 - 11626
  • [24] Structure and function of the cystic fibrosis transmembrane conductance regulator
    Morales, MM
    Capella, MAM
    Lopes, AG
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (08) : 1021 - 1028
  • [25] The Extrapulmonary Effects of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Cystic Fibrosis
    Sergeev, Valentine
    Chou, Frank Y.
    Lam, Grace Y.
    Hamilton, Christopher Michael
    Wilcox, Pearce G.
    Quon, Bradley S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (02) : 147 - 154
  • [26] PHOSPHORYLATION OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
    PICCIOTTO, MR
    COHN, JA
    BERTUZZI, G
    GREENGARD, P
    NAIRN, AC
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (18) : 12742 - 12752
  • [27] THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE
    TSUI, LC
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 151 (03) : S47 - S53
  • [28] Cystic fibrosis transmembrane conductance regulator and adenosine triphosphate
    Abraham, EH
    Okunieff, P
    Scala, S
    Vos, P
    Oosterveld, MJS
    Chen, AY
    Shrivastav, B
    Guidotti, G
    SCIENCE, 1997, 275 (5304) : 1324 - 1325
  • [29] Pharmacology of CFTR (cystic fibrosis transmembrane conductance regulator)
    Cuthbert, A. W.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 22 - 22
  • [30] A transistor model for the cystic fibrosis transmembrane conductance regulator
    Hunt, William D.
    Mccarty, Nael A.
    Marin, Eduardo Martinez
    Westafer, Ryan S.
    Yamin, Phillip R.
    Cui, Guiying
    Eckford, Andrew W.
    Denison, Douglas R.
    BIOPHYSICAL REPORTS, 2023, 3 (02):